Literature DB >> 23926108

Galectin-3 guides intracellular trafficking of some human serotransferrin glycoforms.

Michael C Carlsson1, Per Bengtson, Helena Cucak, Hakon Leffler.   

Abstract

Transferrin internalization via clathrin-mediated endocytosis and subsequent recycling after iron delivery has been extensively studied. Here we demonstrate a previously unrecognized parameter regulating this recycling, the binding of galectin-3 to particular glycoforms of transferrin. Two fractions of transferrin, separated by affinity chromatography based on their binding or not to galectin-3, are targeted to kinetically different endocytic pathways in HFL-1 cells expressing galectin-3 but not in SKBR3 cells lacking galectin-3; the SKBR3 cells, however, can acquire the ability to target these transferrin glycoforms differently after preloading with exogenously added galectin-3. In all, this study provides the first evidence of a functional role for transferrin glycans, in intracellular trafficking after uptake. Moreover, the galectin-3-bound glycoform increased in cancer, suggesting a pathophysiological regulation. These are novel aspects of transferrin cell biology, which has previously considered only a degree of iron loading, but not other forms of heterogeneity.

Entities:  

Keywords:  Breast Cancer; Endocytosis; Galectin-3; Glycoforms; Glycosylation; Trafficking; Transferrin

Mesh:

Substances:

Year:  2013        PMID: 23926108      PMCID: PMC3784757          DOI: 10.1074/jbc.M113.487793

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  50 in total

1.  Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas.

Authors:  Xian P Jiang; Robert L Elliott; Jonathan F Head
Journal:  Anticancer Res       Date:  2010-03       Impact factor: 2.480

2.  Varied expression and localization of multiple galectins in different cancer cell lines.

Authors:  Arun Satelli; Prema S Rao; Prem K Gupta; Paul R Lockman; Kalkunte S Srivenugopal; U Subrahmanyeswara Rao
Journal:  Oncol Rep       Date:  2008-03       Impact factor: 3.906

Review 3.  Pathways and mechanisms of endocytic recycling.

Authors:  Barth D Grant; Julie G Donaldson
Journal:  Nat Rev Mol Cell Biol       Date:  2009-09       Impact factor: 94.444

Review 4.  N-Glycans in cancer progression.

Authors:  Ken S Lau; James W Dennis
Journal:  Glycobiology       Date:  2008-08-13       Impact factor: 4.313

5.  Serum proteome profiling of metastatic breast cancer using recombinant antibody microarrays.

Authors:  Anders Carlsson; Christer Wingren; Johan Ingvarsson; Peter Ellmark; Bo Baldertorp; Mårten Fernö; Håkan Olsson; Carl A K Borrebaeck
Journal:  Eur J Cancer       Date:  2008-01-02       Impact factor: 9.162

Review 6.  Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents.

Authors:  D R Richardson; D S Kalinowski; S Lau; P J Jansson; D B Lovejoy
Journal:  Biochim Biophys Acta       Date:  2008-04-27

7.  Studies of arginine-arene interactions through synthesis and evaluation of a series of galectin-binding aromatic lactose esters.

Authors:  Ian Cumpstey; Emma Salomonsson; Anders Sundin; Hakon Leffler; Ulf J Nilsson
Journal:  Chembiochem       Date:  2007-08-13       Impact factor: 3.164

8.  Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation.

Authors:  Ken S Lau; Emily A Partridge; Ani Grigorian; Cristina I Silvescu; Vernon N Reinhold; Michael Demetriou; James W Dennis
Journal:  Cell       Date:  2007-04-06       Impact factor: 41.582

9.  Different affinity of galectins for human serum glycoproteins: galectin-3 binds many protease inhibitors and acute phase proteins.

Authors:  Cecilia Cederfur; Emma Salomonsson; Jonas Nilsson; Adnan Halim; Christopher T Oberg; Göran Larson; Ulf J Nilsson; Hakon Leffler
Journal:  Glycobiology       Date:  2008-02-09       Impact factor: 4.313

10.  Galectin-4-regulated delivery of glycoproteins to the brush border membrane of enterocyte-like cells.

Authors:  Laurence Stechly; Willy Morelle; Anne-Frédérique Dessein; Sabine André; Georges Grard; Dave Trinel; Marie-José Dejonghe; Emmanuelle Leteurtre; Hervé Drobecq; Germain Trugnan; Hans Joachim Gabius; Guillemette Huet
Journal:  Traffic       Date:  2009-01-24       Impact factor: 6.215

View more
  7 in total

1.  Galectin binding to cells and glycoproteins with genetically modified glycosylation reveals galectin-glycan specificities in a natural context.

Authors:  Mathias Ingemann Nielsen; John Stegmayr; Oliver C Grant; Zhang Yang; Ulf J Nilsson; Irene Boos; Michael C Carlsson; Robert J Woods; Carlo Unverzagt; Hakon Leffler; Hans H Wandall
Journal:  J Biol Chem       Date:  2018-11-01       Impact factor: 5.157

Review 2.  Glycosylation and raft endocytosis in cancer.

Authors:  Ludger Johannes; Anne Billet
Journal:  Cancer Metastasis Rev       Date:  2020-06       Impact factor: 9.264

3.  Glycosylation Profile of the Transferrin Receptor in Gestational Iron Deficiency and Early-Onset Severe Preeclampsia.

Authors:  Alejandra María Gómez-Gutiérrez; Beatriz Elena Parra-Sosa; Julio Cesar Bueno-Sánchez
Journal:  J Pregnancy       Date:  2019-02-03

4.  Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease.

Authors:  Antonio Boza-Serrano; Rocío Ruiz; Raquel Sanchez-Varo; Juan García-Revilla; Yiyi Yang; Itzia Jimenez-Ferrer; Agnes Paulus; Malin Wennström; Anna Vilalta; David Allendorf; Jose Carlos Davila; John Stegmayr; Sebastian Jiménez; Maria A Roca-Ceballos; Victoria Navarro-Garrido; Maria Swanberg; Christine L Hsieh; Luis M Real; Elisabet Englund; Sara Linse; Hakon Leffler; Ulf J Nilsson; Guy C Brown; Antonia Gutierrez; Javier Vitorica; Jose Luis Venero; Tomas Deierborg
Journal:  Acta Neuropathol       Date:  2019-04-20       Impact factor: 17.088

Review 5.  Clathrin-independent endocytosis, retrograde trafficking, and cell polarity.

Authors:  Massiullah Shafaq-Zadah; Estelle Dransart; Ludger Johannes
Journal:  Curr Opin Cell Biol       Date:  2020-07-17       Impact factor: 8.382

6.  Cell Type- and Stimulation-Dependent Transcriptional Programs Regulated by Atg16L1 and Its Crohn's Disease Risk Variant T300A.

Authors:  Mukund Varma; Motohiko Kadoki; Ariel Lefkovith; Kara L Conway; Kevin Gao; Vishnu Mohanan; Betsabeh Khoramian Tusi; Daniel B Graham; Isabel J Latorre; Andrew C Tolonen; Bernard Khor; Aylwin Ng; Ramnik J Xavier
Journal:  J Immunol       Date:  2020-06-10       Impact factor: 5.422

Review 7.  Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z.

Authors:  Salvatore Sciacchitano; Luca Lavra; Alessandra Morgante; Alessandra Ulivieri; Fiorenza Magi; Gian Paolo De Francesco; Carlo Bellotti; Leila B Salehi; Alberto Ricci
Journal:  Int J Mol Sci       Date:  2018-01-26       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.